← Home / IRONWOOD PHARMACEUTICALS, INC. (IRWD)
Stock Analysis
IRONWOOD PHARMACEUTICALS, INC. (IRWD)
IRWD
IRWD · Market data
4.23 +13.40%
Track IRWD in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IRWD price is:
52W Range Position
75%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-02 16:43 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 5.39. Holding above 3.92 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Strong
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
3.92
↗
Break Above
Confirmation improves above resistance.
5.39
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 3.92
Recent Company Events
SEC VERIFIED
Latest material filings
JUN
18
●
Management / Board
MEDIUM
IRWD board and management update
On June 16, 2026, Ironwood Pharmaceuticals, Inc.
8-K Filing • SEC EDGAR
JUN
15
$
Debt Financing
HIGH
IRWD debt financing update
On June 15, 2026, Ironwood Pharmaceuticals, Inc.
8-K Filing • SEC EDGAR
MAY
13
●
Management / Board
MEDIUM
IRWD board and management update
On May 8, 2026, Gregory Martini notified Ironwood Pharmaceuticals, Inc.
8-K Filing • SEC EDGAR
What's Driving IRWD?
📈 Technical recovery is improving
Momentum is Neutral. Watch 5.39 for confirmation and 3.92 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 3.92
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
57.4
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 3.92 and resistance at 4.76. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
IRWD — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Spec
Speculative premium
Earnings are negative, but the stock still trades at high expectation multiples.
Market Cap
$696.3M
Company size
EV
$796.0M
Debt-adjusted value
P/S
14.6
Premium
P/B
-3.2
Not meaningful
EV/Sales
16.7
Premium
EV/EBIT
8.1
Low multiple
P/FCF
6.2
Low multiple
FCF Yield
16.11%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Strong financial quality
Growth, profitability, cash flow and balance sheet quality remain broadly supportive.
↗
Revenue Growth
Strong
●
Profitability
Strong
≈
Cash Flow
Healthy
⚖
Balance Sheet
Strong
💵 Revenue
106.51M
↗ Strong
📈 Net Income
40.77M
↗ Strong
🧮 EPS (Basic)
0.25
↗ Strong
IRONWOOD PHARMACEUTICALS, INC.
Related Opportunities